-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$65.33188.05% Upside
Bicycle Therapeutics plc Frequently Asked Questions
-
What analysts cover Bicycle Therapeutics plc?
Bicycle Therapeutics plc has been rated by research analysts at H.C. Wainwright, Piper Sandler, Roth Capital in the past 90 days.